Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies-Reference-Cited by-同舟云学术

Bruton’s Tyrosine Kinase Inhibitors: Approaches to Potent and Selective Inhibition, Preclinical and Clinical Evaluation for Inflammatory Diseases and B Cell Malignancies

Published:2012-03-21 Issue:10 Volume:55 Page:4539-4550
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Lou Yan¹,Owens Timothy D.¹,Kuglstatter Andreas¹,Kondru Rama K.¹,Goldstein David M.¹

Affiliation:

1. Discovery Chemistry, Small Molecule Research, pRED, Pharma Research and Early Development, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm300035p

Reference79 articles.

1. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases

2. Primary B Cell Immunodeficiencies: Comparisons and Contrasts

3. A review of the current use of rituximab in autoimmune diseases

4. Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview of pyridazin-3(2 H )-one: a core for developing bioactive agents targeting cardiovascular diseases and cancer;Future Medicinal Chemistry;2024-08-06

2. Cardiovascular toxicity of Bruton tyrosine kinase inhibitors: forget about selectivity but watch the clock;Blood Advances;2024-07-12

3. Medicinal perspectives and structure-activity relationship studies of pyrimidine based Bruton’s tyrosine kinase inhibitors as potential anticancer agents;Process Biochemistry;2023-09

4. Virtual screening and structure–activity relationship study of novel BTK inhibitors in Traditional Chinese Medicine for the treatment of rheumatoid arthritis;Journal of Biomolecular Structure and Dynamics;2023-03-13

5. Development of novel hydrazidoarylaminopyrimidine-based BTK/FLT3 dual inhibitors with potent in vivo anti-hematological malignancies effects;European Journal of Medicinal Chemistry;2023-01